Business Standard

Friday, January 10, 2025 | 09:51 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Page 9 - Pharmaceuticals

Lupin and Boehringer Ingelheim ink co-marketing pact for diabetes drug empagliflozin

While Lupin will market empagliflozin under the brand name of Gibtulio, Boehringer Ingelheim will continue to sell it under Jardiance brand in India

Lupin and Boehringer Ingelheim ink co-marketing pact for diabetes drug empagliflozin
Updated On : 13 Oct 2016 | 5:29 PM IST

Intas Pharma acquires Teva's UK and Ireland assets for GBP 603 mn

Acquisition will help Intas to strengthen its presence in European healthcare sector, one of its key overseas markets

Intas Pharma acquires Teva's UK and Ireland assets for GBP 603 mn
Updated On : 05 Oct 2016 | 9:17 PM IST

Novo Nordisk to layoff 1,000 employees globally

This is one of several actions taken to reduce operating costs as the company faces a challenging competitive environment in 2017, especially in its large US market

Novo Nordisk to layoff 1,000 employees globally
Updated On : 30 Sep 2016 | 3:05 PM IST

Zydus ties up with Medicines for Malaria Venture to co-develop antimalarial drug

The Ahmedabad-based pharma major will lead the development of the novel compound, which was discovered by MMV in collaboration with AstraZeneca, India

Zydus ties up with Medicines for Malaria Venture to co-develop antimalarial drug
Updated On : 30 Sep 2016 | 11:58 AM IST

Sanofi to get $ 43.2 mn from US HHS to fund Zika vaccine research

The funds will be used for phase II development and manufacturing of an inactivated Zika vaccine

Sanofi to get $ 43.2 mn from US HHS to fund Zika vaccine research
Updated On : 27 Sep 2016 | 5:09 PM IST

Cambrex acquires PharmaCore to expand clinical stage API capabilities

The acquisition will enhance Cambrex's portfolio of small molecule API services and complements its existing large scale, multi-purpose manufacturing facilities in the US and Europe

Cambrex acquires PharmaCore to expand clinical stage API capabilities
Updated On : 27 Sep 2016 | 5:05 PM IST

Pfizer completes sale of 4 products to Piramal Enterprises

In May 2016, the US-based pharma major entered into an agreement with Piramal Enterprises to sell its four products for a total consideration of Rs 110 crores

Pfizer completes sale of 4 products to Piramal Enterprises
Updated On : 27 Sep 2016 | 2:39 PM IST

Novasep and Triclinic Labs to jointly develop solid-state chemistry services

Partnership will enable Novasep to offer early-stage solid-state chemistry services in North America

Novasep and Triclinic Labs to jointly develop solid-state chemistry services
Updated On : 20 Sep 2016 | 6:36 PM IST

Dr Reddy's launches vitamin D analog paricalcitol injection in US

The approved product is the generic version of Abbvie Inc's Zemplar injection

Dr Reddy's launches vitamin D analog paricalcitol injection in US
Updated On : 20 Sep 2016 | 6:33 PM IST

Dr Reddy's expands collaboration with US-based Amgen in India

As per the deal, the company will market and distribute Amgen's three medicines in India in the therapy areas of oncology and osteoporosis

Dr Reddy's expands collaboration with US-based Amgen in India
Updated On : 17 Sep 2016 | 2:00 PM IST

Protein Sciences bags mega contract from US HHS for influenza vaccines

The company stands to receive up to $ 610 million through 2021 if US Biomedical Advanced Research and Development Authority (BARDA) exercises all options

Protein Sciences bags mega contract from US HHS for influenza vaccines
Updated On : 14 Sep 2016 | 10:06 AM IST

Indoco Remedies receives six 483s for Goa plant from US FDA

Form 483s were issued after the US drug regulator inspected the company's Goa plant II in connection with ANDA filings for injectable

Indoco Remedies receives six 483s for Goa plant from US FDA
Updated On : 08 Sep 2016 | 1:46 PM IST

Sun Pharma ropes in Mitsubishi Tanabe to distribute products in Japan

Mitsubishi Tanabe Pharma Corporation will market and distribute 14 brands, which were acquired by Sun Pharma earlier this year from Novartis Pharma KK

Sun Pharma ropes in Mitsubishi Tanabe to distribute products in Japan
Updated On : 06 Sep 2016 | 12:14 PM IST

Jubilant Life receives US FDA approval for hypertension drug telmisartan

The approved product - telmisartan tablet - is a generic version of Boehringer Ingelheim Pharmaceuticals' Micardis tablet

Jubilant Life receives US FDA approval for hypertension drug telmisartan
Updated On : 24 Aug 2016 | 12:39 PM IST

Germany's Fresenius Kabi to invest $ 250 mn to expand US manufacturing plant

The expansion, which will take place over the next 10 years, will significantly increase Fresenius Kabi's capacity to produce injectable generic pharmaceuticals

Germany's Fresenius Kabi to invest $ 250 mn to expand US manufacturing plant
Updated On : 23 Aug 2016 | 12:05 PM IST

Cadila Healthcare receives US FDA's EIR report for Ahmedabad facility

The company has received an Establishment Inspection Report (EIR) from the US drug regulator for its topical manufacturing facility located at Changodar (Ahmedabad)

Image
Updated On : 16 Aug 2016 | 2:39 PM IST

Teva acquires US-based drug distributor Anda for $ 500 mn

Acquisition of Anda Inc, the fourth largest distributor of generic pharmaceuticals in the US, will significantly strengthen Teva's extensive supply chain network in the US

Teva acquires US-based drug distributor Anda for $ 500 mn
Updated On : 09 Aug 2016 | 4:23 PM IST

Aurobindo Pharma receives US FDA nod for anti-infective drug

The approved product, linezolid injection 600 mg/300 mL (2 mg/mL), has an estimated market size of $ 87 million for the twelve months ending June 2016, according to IMS

Aurobindo Pharma receives US FDA nod for anti-infective drug
Updated On : 08 Aug 2016 | 2:11 PM IST

Zydus acquires derma brand Melgain from Issar Pharma

With the acquisition of Melgain, used for the treatment of vitiligo, Zydus will strengthen its position in the Rs 6000 crore dermatology market

Zydus acquires derma brand Melgain from Issar Pharma
Updated On : 08 Aug 2016 | 1:27 PM IST

Ajanta Pharma receives US FDA approval for heartburn drug

The approved product, omeprazole and sodium bicarbonate powder for oral suspension, is a bioequivalent generic version of Salix Pharmaceuticals' Zegerid powder

Image
Updated On : 04 Aug 2016 | 1:30 PM IST